Clinical Trials on MEASLES DISEASE

Total 376492 results

Postgraduate Institute of Medical Education and...

Unknown

Randomized Controlled Trial of Measles Vaccination Schedule

MEASLES DISEASE

India
Bandim Health Project
Heidelberg University; Centre de Recherche en Sante de Nouna, Burkina Faso; Navrongo... and other collaborators

Unknown

Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.

Measles Vaccine

Burkina Faso
Bandim Health Project

Unknown

Additional Measles Vaccine at 4 Months of Age

Measles Infection

Guinea-Bissau
Bandim Health Project
Heidelberg University; Centre de Recherche en Sante de Nouna, Burkina Faso; Navrongo... and other collaborators

Unknown

Trial of Additional Measles Vaccine to Reduce Child Mortality

Measles Vaccine

Guinea-Bissau
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination

Measles/Rubella

Japan
Serum Institute of India Pvt. Ltd.
Centers for Disease Control and Prevention; University of Colorado, Boulder

Completed

A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices (PMV-001)

Prophylaxis for the Measles Infection

India
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

Measles/Rubella
Bandim Health Project

Enrolling by invitation

Measles Vaccination at Health System Contacts

Mortality | Measles Vaccine | Hospital Admission | Non-specific (Heterologous) Effects of Vaccines

Guinea-Bissau
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico
The Immunobiological Technology Institute (Bio-Manguinhos)...

Not yet recruiting

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Measles Vaccine
Bandim Health Project
Medical Research Council Unit, The Gambia

Completed

Prophylactic Antibiotics in Measles

Measles | Post-Measles Pneumonia

Guinea-Bissau
Bandim Health Project
Statens Serum Institut; Research Center for Vitamins and Vaccines

Unknown

Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children (RE-CAMP)

Mortality | Children | Oral Polio Vaccine | Morbidity | Measles Vaccination | Non-specific/Heterologous Effects of Vaccines

Guinea-Bissau
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

Finland, Thailand, United States, Spain, Czechia, Puerto Rico, Malaysia
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Measles-Mumps-Rubella

Taiwan, United States, Korea, Republic of
National Institute of Allergy and Infectious Diseases...
Johns Hopkins University

Recruiting

Investigation of Immune Amnesia Following Measles Infection in Select African Regions

Measles Infection

Guinea, Mali
PATH

Completed

Coadministration of Measles-rubella and Rotavirus Vaccines

Measles Antibody Seroconversion | Rubella Antibody Seroconversion | Rotavirus Geometric Mean Titer (GMT) | Rotavirus Immunoglobulin A (IgA) Seropositivity

Bangladesh
GlaxoSmithKline

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

United States, Puerto Rico
IDinsight
GiveWell

Completed

Measles Vaccination Cash Incentives Experimental Evidence From Nigeria

Measles

Nigeria
Bavarian Nordic

Completed

Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years

Measles

South Africa
Bandim Health Project
Novo Nordisk A/S; Danish Council for Development Research; Fonden til Lægevidenskabens... and other collaborators

Completed

Long-term Follow-up of Measles Antibodies

Measles

Guinea-Bissau
Danat Al Emarat Hospital

Not yet recruiting

Quadratus Lumborum Block After Cesarean Section: Analgesic Efficacy of Different Concentrations of Local Anesthetics

Outcome Measures
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed

Measles

Brazil
Dilla University

Not yet recruiting

Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial

Measles

Ethiopia
University of Rochester
American Cancer Society, Inc.

Completed

Primary Care Based Randomized Trial to Reduce Cancer Screening Disparities (Get Screened)

Preventive Measures
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?

Covid19 | Mortality | Measles Vaccine

Turkey
Bandim Health Project
Institudo Nacional de Saude Publica INASA

Completed

The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age (MVEPI)

Mortality | Vaccines

Guinea-Bissau
Institut Pasteur de Dakar
Epicentre; Ministry of Health, Senegal

Not yet recruiting

Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal

Measles
Marmara University

Completed

Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience

Measles

Turkey
Stanford University

Completed

Ontogeny of Measles Immunity in Infants

Measles

United States
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; Kenya Medical Research Institute

Completed

Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial (M-SIMI)

Measles
Bandim Health Project

Unknown

mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau (mimi)

Measles

Guinea-Bissau
Queen Saovabha Memorial Institute

Unknown

Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors

Measles

Thailand
Bandim Health Project
Danish Council for Development Research; Medical Research Council Unit, The... and other collaborators

Completed

Non-Specific Effects of Standard Titre Measles Vaccination

Measles

Guinea-Bissau
GlaxoSmithKline

Recruiting

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Measles; Mumps; Rubella; Chickenpox

United States
American Society for Gastrointestinal Endoscopy
Midwest Biomedical Research Foundation

Unknown

A Randomized Controlled Trial Of Endoscopic Ultrasound-Guided Fine-Needle Aspiration With And Without A Stylet

Mediastinal or Intra-abdominal Lymphadenopathy, | Pancreatic Masses, | Left Adrenal Masses, | Gastrointestinal Submucosal Lesions, and | Liver Masses

United States
Mead Johnson Nutrition
University of Kansas Medical Center

Completed

Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance

Behavioral Measures of Tolerance

United States
Charite University, Berlin, Germany
Federal Ministry of Health, Germany

Completed

Effects of a Standardized Post-coercion Review Session.

Coercive Measures

Germany
Hospices Civils de Lyon

Recruiting

Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients (MaRROwVacc)

Transplantation, Hematopoietic Stem Cell

France
Bandim Health Project

Completed

A Second Dose of Measles Vaccine (MV) in the Second Year of Life

Child Mortality | Child Morbidity

Guinea-Bissau
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

Measles

Zambia
Merck Sharp & Dohme LLC

Completed

ProQuad® Intramuscular vs Subcutaneous

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Klara M. Pósfay Barbe
University Hospital, Geneva

Recruiting

Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients (MMRinOLT)

Measles

Switzerland
Merck Sharp & Dohme LLC

Completed

A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)

Measles
University Health Network, Toronto

Withdrawn

Comparison of OpeN VErsus RoboTic Partial Nephrectomy (CONVERT)

Renal Masses

Canada
Brugmann University Hospital

Completed

Adnexal Masses : Correlation Between MRI (Magnetic Resonance Imagery) and Anatomopathology

Adnexal Masses

Belgium
Asan Medical Center

Completed

Optimal Number of To-and-fro Motion in EUS-guided Fine Needle Aspiration for Pancreatic Masses

Pancreatic Masses

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

Measles | Rubella | Mumps | Varicella
The University of Tennessee, Knoxville

Completed

The Effects of Exercise on Dietary Intake

Active Lifestyle Males | Inactive Lifestyle Males

United States

Clinical Trials on MEASLES DISEASE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations